Plus Therapeutics, Inc. (CNSY) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.6x

Market Cap

$20.87M

MomentumView details →

1D Return

−7.72%

YTD Return

—

RSI (14)

35.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.6x

Market Cap

$20.87M

RSI (14)

35.9

MomentumView details →

1D Return

−7.72%

YTD Return

—

ProfitabilityView details →

Gross Margin

89.58%

Net Margin

−620.70%

EBITDA Margin

−532.71%

ROE (TTM)

−477.54%

ROA (TTM)

−185.94%

Asset Turnover

0.25x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+185.50%

EPS CAGR 3Y

+85.25%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$1.31

EPS Surprise

−48.86%

Beats (12Q)

0/12

Next Q EPS Est

−$0.89

Avg Surprise (4Q)

−48.86%

Rev Surprise

−63.08%

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

1.37x

Quick Ratio

1.37x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

4.20M

Net Income (TTM)

−26.09M

Op. CF (TTM)

−22.18M

Next earningsOct 29, 2026 →

Latest newsMore news →

No recent news for CNSY.

Similar companies

Neuphoria Therapeutics Inc.NEUP Hoth Therapeutics, Inc.RKTO Pa Shun International Holdings Limited00574.HK Sanai Health Industry Group Company Limited01889.HK AIxCrypto Holdings, Inc.AIXC 111, Inc.YI Find similar companies →

Latest newsMore news →

No recent news for CNSY.